1. Home
  2. ADAP vs DHX Comparison

ADAP vs DHX Comparison

Compare ADAP & DHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • DHX
  • Stock Information
  • Founded
  • ADAP 2008
  • DHX 1991
  • Country
  • ADAP United Kingdom
  • DHX United States
  • Employees
  • ADAP N/A
  • DHX N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • DHX Business Services
  • Sector
  • ADAP Health Care
  • DHX Consumer Discretionary
  • Exchange
  • ADAP Nasdaq
  • DHX Nasdaq
  • Market Cap
  • ADAP 75.5M
  • DHX 89.7M
  • IPO Year
  • ADAP 2015
  • DHX 2007
  • Fundamental
  • Price
  • ADAP $0.27
  • DHX $2.93
  • Analyst Decision
  • ADAP Buy
  • DHX Strong Buy
  • Analyst Count
  • ADAP 6
  • DHX 2
  • Target Price
  • ADAP $1.35
  • DHX $5.25
  • AVG Volume (30 Days)
  • ADAP 644.7K
  • DHX 105.2K
  • Earning Date
  • ADAP 08-11-2025
  • DHX 08-06-2025
  • Dividend Yield
  • ADAP N/A
  • DHX N/A
  • EPS Growth
  • ADAP N/A
  • DHX N/A
  • EPS
  • ADAP N/A
  • DHX N/A
  • Revenue
  • ADAP $179,639,000.00
  • DHX $138,202,000.00
  • Revenue This Year
  • ADAP N/A
  • DHX N/A
  • Revenue Next Year
  • ADAP $35.48
  • DHX $0.88
  • P/E Ratio
  • ADAP N/A
  • DHX N/A
  • Revenue Growth
  • ADAP 878.53
  • DHX N/A
  • 52 Week Low
  • ADAP $0.20
  • DHX $1.21
  • 52 Week High
  • ADAP $1.48
  • DHX $3.34
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 56.59
  • DHX 58.87
  • Support Level
  • ADAP $0.23
  • DHX $2.85
  • Resistance Level
  • ADAP $0.28
  • DHX $2.99
  • Average True Range (ATR)
  • ADAP 0.02
  • DHX 0.21
  • MACD
  • ADAP 0.00
  • DHX -0.02
  • Stochastic Oscillator
  • ADAP 87.96
  • DHX 49.39

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

Share on Social Networks: